AKBA - Akebia Q1 2024 Earnings Preview
2024-05-08 11:42:17 ET
More on Akebia
- Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management
- Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade)
- Akebia stock jumps as FDA clears renal anemia therapy
- Akebia GAAP EPS of $0.00 beats by $0.04, revenue of $56.2M beats by $0.81M
- Seeking Alpha’s Quant Rating on Akebia